U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Search Results

Cisplatin Injection
Status: Resolved
»Duration of Shortage: 02/10/2023 - 06/27/2024
»Therapeutic Categories: Oncology; Pediatric

Expand all

Accord Healthcare Inc. (Revised 06/27/2024)

Company Contact Information:
866-941-7875, option 2

Presentation
  • Injection, 50 mL vial, 1 mg/mL (NDC 16729-288-11)
  • Injection, 100 mL vial, 1 mg/mL (NDC 16729-288-38)
Note:
  • Available

Fresenius Kabi USA, LLC (Revised 06/27/2024)

Company Contact Information:
888-386-1300

Presentation
  • Injection, 50 mL vial, 1 mg/mL (NDC 63323-103-51)
  • Injection, 100 mL vial, 1 mg/mL (NDC 63323-103-65)
  • Injection, 200 mL vial, 1 mg/mL (NDC 63323-103-64)
Note:
  • Available

Gland Pharma Limited (Revised 06/27/2024)

Company Contact Information:
Sagent Pharmaceuticals: 866-625-1618; Fosun Pharma USA Inc.: 855-282-4882

Presentation
  • Injection, 50 mL vial, 1 mg/mL (NDC 25021-253-50)
  • Injection, 100 mL vial, 1 mg/mL (NDC 25021-253-51)
  • Injection, 50 mL vial, 1 mg/mL (NDC 72266-252-01)
  • Injection, 100 mL vial, 1 mg/mL (NDC 72266-253-01)
Note:
  • Available. NDC 25021-253-50 and NDC 25021-253-51 marketed by Sagent Pharmaceuticals. NDC 72266-252-01 and NDC 72266-253-01) marketed by Fosun Pharma USA Inc.

Hikma Pharmaceuticals USA, Inc. (Revised 06/27/2024)

Company Contact Information:
800-631-2174

Presentation
  • Injection, 50 mL vial, 1 mg/mL (NDC 0143-9504-01)
  • Injection, 100 mL vial, 1 mg/mL (NDC 0143-9505-01)
Note:
  • Available

HQ Specialty Pharma (Revised 06/27/2024)

Company Contact Information:
WG Critical Care 888-493-0861

Presentation
  • Injection, 200 mL vial, 1 mg/mL (NDC 44567-511-01)
  • Injection, 50 mg (NDC 44567-530-01)
Note:
  • Available. Marketed by WG Critical Care.

Qilu Pharmaceutical Co., Ltd. (Revised 06/27/2024)

Company Contact Information:
Apotex Corp.: 800-706-5575

Presentation
  • Injection, 50 mL vial, 1 mg/mL (NDC 60505-6279-0)
Note:
  • Estimated availability August 2024. Marketed by Apotex Corp.

Teva Pharmaceuticals USA, Inc. (Revised 06/27/2024)

Company Contact Information:
800-545-8800

Presentation
  • Injection, 50 mL vial, 1 mg/mL (NDC 0703-5747-11)
  • Injection, 100 mL vial, 1 mg/mL (NDC 0703-5748-11)
Note:
  • Available
Back to Top